Results 11 to 20 of about 2,848,507 (217)
Secondary and tertiary hyperparathyroidism in chronic kidney disease [PDF]
Остеопороз и остеопатии, 2017 In the treatment of secondary hyperparathyroidism of end-stage chronic kidney disease, vitamin D receptor activation and allosteric modulators of the calcium-sensing receptor inhibit glandular hyperplasia, reduce parathyroid hormone levels, impact on ...
Lilit V. Egshatyan +2 more
doaj +2 more sources
PARATHYROID CANCER OCCURRING IN RELAPSING SECONDARY HYPERPARATHYROIDISM
Alʹmanah Kliničeskoj Mediciny, 2016 We present a clinical case of parathyroid cancer in a patient with relapsing secondary hyperparathyroidism at 4 years after subtotal parathyroidectomy.
I. V. Kotova +2 more
doaj +2 more sources
Challenges in differential diagnosis between primary and secondary forms of hyperparathyroidism [PDF]
Ожирение и метаболизм, 2017 Hyperparathyroidism is a disease characterized by excessive secretion of parathyroid hormone (PTH) in the chief cells of parathyroid glands. There are three types of hyperparathyroidism: primary, secondary, and tertiary depending on the cause of this ...
Natalia G. Mokrysheva +3 more
doaj +2 more sources
Prevalence of Secondary Hyperparathyroidism in Hemo- Dialysis Patients
ProceedingsIntroduction: One persistent complication of chronic kidney disease is secondary hyperparathyroidism. Early diagnosis of this disease will reduce morbidity in patients undergoing hemodialysis.
Awais Amjad +4 more
doaj +2 more sources
Secondary and Tertiary Hyperparathyroidism
, 2018 Secondary hyperparathyroidism (SHP) is a frequent complication of kidney diseases. At variance with all the other forms of SHP, which are compensatory conditions, renal SHP has many pathogenetic peculiarities, which have been only in part defined.
Piergiorgio, Messa, Carlo Maria, Alfieri
openaire +3 more sources
DIAGNOSTICS AND TREATMENT OF PRIMARY AND SECONDARY HYPERPARATHYROIDISM
Вестник хирургии имени И.И. Грекова, 2018 The experience of treatment of 41 patients (aged 32–67years) was presented in the article. The duration of disease was 2–5 years. Primary hyperparathyroidism was diagnosed in 16 patients and secondary — in 25. Diagnostics of the disease included clinical
M. F. Zarivchatskiy +4 more
doaj +2 more sources
Pathogenesis of secondary hyperparathyroidism [PDF]
Nephrology Dialysis Transplantation, 1994 The past 20 years has witnessed a dramatic improvement in our understanding of the factors involved in the pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency. The major causes are retention of phosphorus, relatively low levels of serum calcium, and decreased 1,25-(OH)2D3 (calcitriol) levels.
E, Slatopolsky, J A, Delmez
openaire +4 more sources
Pathogenesis of Secondary Hyperparathyroidism [PDF]
The International Journal of Artificial Organs, 2009 Chronic renal failure is the primary cause of secondary hyperparathyroidism (SHPT). Patients with mineral metabolism disorders commonly present with low serum calcium levels, hyperphosphatemia, and calcitriol deficiency. In normal renal function subjects, parathyroid cells have a low turnover and rarely undergo mitoses.
M.G. Cozzolino +5 more
openaire +3 more sources
European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism
BJS (British Journal of Surgery), EarlyView., 2020 Some 5861 patients undergoing first‐time surgery for sporadic primary hyperparathyroidism were registered in the Eurocrine® database between 2015 and 2018. The use of intraoperative parathyroid hormone measurement decreased the risk of conversion and persistent hypercalcaemia.
A. Bergenfelz +3 more
wiley +1 more source
BJS (British Journal of Surgery), EarlyView., 2020 This study investigated postoperative complications after surgery for medullary thyroid carcinoma (MTC) in Europe. Hypoparathyroidism, recurrent laryngeal nerve palsy and bleeding requiring reoperation occurred in 170 (26·2 per cent), 62 (13·7 per cent) and 17 (2·6 per cent) patients respectively.
D.‐J. van Beek +18 more
wiley +1 more source